Financhill
Buy
57

CLMB Quote, Financials, Valuation and Earnings

Last price:
$123.74
Seasonality move :
8.69%
Day range:
$118.25 - $127.75
52-week range:
$48.67 - $142.50
Dividend yield:
0.55%
P/E ratio:
33.62x
P/S ratio:
1.34x
P/B ratio:
6.52x
Volume:
46.3K
Avg. volume:
34K
1-year change:
117.88%
Market cap:
$571.5M
Revenue:
$352M
EPS (TTM):
$3.69
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $208.8M $251.6M $282.6M $304.3M $352M
Revenue Growth (YoY) 15.05% 20.51% 12.33% 7.7% 15.66%
 
Cost of Revenues $178.8M $218.5M $236.9M $250.3M $287.8M
Gross Profit $30M $33M $45.7M $54.1M $64.2M
Gross Profit Margin 14.36% 13.13% 16.18% 17.77% 18.25%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $21M $25.5M $32.1M $34.1M $44.3M
Other Inc / (Exp) $82K -$722K -$46K -$1.5M -$1.3M
Operating Expenses $21.5M $26.2M $33.7M $36.2M $47.1M
Operating Income $8.5M $6.8M $12.1M $17.9M $17.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $9M $6.2M $12.4M $16.5M $16.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.3M $1.7M $3.2M $4M $4.5M
Net Income to Company $6.8M $4.5M $9.2M $12.5M $12.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.8M $4.5M $9.2M $12.5M $12.3M
 
Basic EPS (Cont. Ops) $1.51 $1.01 $2.09 $2.81 $2.72
Diluted EPS (Cont. Ops) $1.51 $1.01 $2.09 $2.81 $2.72
Weighted Average Basic Share $4.4M $4.3M $4.3M $4.3M $4.4M
Weighted Average Diluted Share $4.4M $4.3M $4.3M $4.3M $4.4M
 
EBITDA $9.3M $7.9M $14.1M $20.4M $20.3M
EBIT $8.5M $6.8M $12.1M $17.9M $17.1M
 
Revenue (Reported) $208.8M $251.6M $282.6M $304.3M $352M
Operating Income (Reported) $8.5M $6.8M $12.1M $17.9M $17.1M
Operating Income (Adjusted) $8.5M $6.8M $12.1M $17.9M $17.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $60.9M $68.9M $76.3M $78.5M $119.3M
Revenue Growth (YoY) 16.34% 13.12% 10.67% 2.88% 52.12%
 
Cost of Revenues $53.7M $57.6M $62.7M $64.2M $95.1M
Gross Profit $7.2M $11.3M $13.5M $14.3M $24.3M
Gross Profit Margin 11.88% 16.43% 17.73% 18.19% 20.32%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $5.9M $7.8M $8.9M $10.1M $13.9M
Other Inc / (Exp) -$411K -$41K -$865K -$386K -$2.2M
Operating Expenses $6.1M $8.1M $9.5M $10.7M $15.1M
Operating Income $1.2M $3.2M $4M $3.5M $9.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $769K $3.2M $3.2M $3.5M $7.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $239K $756K $999K $1.1M $1.7M
Net Income to Company $530K $2.4M $2.2M $2.4M $5.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $530K $2.4M $2.2M $2.4M $5.5M
 
Basic EPS (Cont. Ops) $0.13 $0.55 $0.50 $0.52 $1.19
Diluted EPS (Cont. Ops) $0.13 $0.55 $0.50 $0.52 $1.19
Weighted Average Basic Share $4.2M $4.3M $4.3M $4.4M $4.5M
Weighted Average Diluted Share $4.2M $4.3M $4.3M $4.4M $4.5M
 
EBITDA $1.4M $3.7M $4.7M $4.3M $10.5M
EBIT $1.2M $3.2M $4M $3.5M $9.1M
 
Revenue (Reported) $60.9M $68.9M $76.3M $78.5M $119.3M
Operating Income (Reported) $1.2M $3.2M $4M $3.5M $9.1M
Operating Income (Adjusted) $1.2M $3.2M $4M $3.5M $9.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $241M $278.5M $291M $334.1M $410.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $210.6M $234.9M $240.4M $274.8M $329.7M
Gross Profit $30.4M $43.7M $50.6M $59.3M $80.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.5M $31.2M $32.9M $41M $51.8M
Other Inc / (Exp) -$730K -$58K -$1.1M -$656K -$3.9M
Operating Expenses $24.3M $32.7M $34.6M $43.7M $55.6M
Operating Income $6M $11M $15.9M $15.6M $25.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $5.5M $11.3M $14.9M $15.8M $22.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.5M $3M $3.7M $4M $5.4M
Net Income to Company $4M $8.3M $11.2M $11.8M $16.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4M $8.3M $11.2M $11.8M $16.9M
 
Basic EPS (Cont. Ops) $0.89 $1.89 $2.52 $2.63 $3.69
Diluted EPS (Cont. Ops) $0.89 $1.89 $2.52 $2.63 $3.69
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $6.9M $12.9M $18.1M $18.6M $29.4M
EBIT $6M $11M $15.9M $15.6M $25.3M
 
Revenue (Reported) $241M $278.5M $291M $334.1M $410.6M
Operating Income (Reported) $6M $11M $15.9M $15.6M $25.3M
Operating Income (Adjusted) $6M $11M $15.9M $15.6M $25.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $180.1M $207.1M $215.4M $245.2M $303.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $157.6M $173.9M $177.5M $202.1M $244M
Gross Profit $22.5M $33.1M $38M $43.2M $59.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.6M $24.3M $25.1M $31.9M $39.4M
Other Inc / (Exp) -$773K -$107K -$1.2M -$377K -$3M
Operating Expenses $19M $25.5M $26.5M $33.9M $42.4M
Operating Income $3.5M $7.7M $11.5M $9.3M $17.5M
 
Net Interest Expenses -- -- $17K -- --
EBT. Incl. Unusual Items $2.8M $7.9M $10.4M $9.7M $15.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $880K $2.2M $2.7M $2.6M $3.6M
Net Income to Company $1.9M $5.8M $7.7M $7.1M $11.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.9M $5.8M $7.7M $7.1M $11.6M
 
Basic EPS (Cont. Ops) $0.44 $1.31 $1.74 $1.57 $2.54
Diluted EPS (Cont. Ops) $0.44 $1.31 $1.74 $1.57 $2.54
Weighted Average Basic Share $12.9M $12.8M $13M $13.2M $13.4M
Weighted Average Diluted Share $12.9M $12.8M $13M $13.2M $13.4M
 
EBITDA $4.2M $9.2M $13.2M $11.6M $20.7M
EBIT $3.5M $7.7M $11.5M $9.3M $17.5M
 
Revenue (Reported) $180.1M $207.1M $215.4M $245.2M $303.8M
Operating Income (Reported) $3.5M $7.7M $11.5M $9.3M $17.5M
Operating Income (Adjusted) $3.5M $7.7M $11.5M $9.3M $17.5M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $15M $29.3M $29.3M $20.2M $36.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $101M $93.8M $122.5M $154.6M $222.3M
Inventory $2.8M $4.9M $2M $4.8M $3.7M
Prepaid Expenses $100K $1.2M $661K $890K --
Other Current Assets $2.7M $3.8M $4.9M $4.1M $6.8M
Total Current Assets $121.5M $133.2M $159.3M $184.6M $269.1M
 
Property Plant And Equipment $3M $4.2M $3.6M $4.8M $9.7M
Long-Term Investments -- -- -- -- --
Goodwill -- $16.8M $17.2M $19M $27.2M
Other Intangibles -- $10.6M $10M $19.7M $26.9M
Other Long-Term Assets $111K $257K $459K $350K $1.1M
Total Assets $126.3M $165.5M $190.8M $231.9M $335.1M
 
Accounts Payable $73.3M $107M $125.9M $151.2M $218.7M
Accrued Expenses $5.1M $9.6M $8.4M $8.5M $22.9M
Current Portion Of Long-Term Debt -- -- -- $520K $540K
Current Portion Of Capital Lease Obligations $383K $490K $475K $521K $450K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $78.7M $117.2M $134.7M $161.7M $250.6M
 
Long-Term Debt -- -- -- $1.3M $752K
Capital Leases -- -- -- -- --
Total Liabilities $81M $120.8M $138.3M $171.3M $260.3M
 
Common Stock $53K $53K $53K $53K $53K
Other Common Equity Adj -$1.1M -$742K -$250K -$2.9M -$522K
Common Equity $45.3M $44.7M $52.4M $60.6M $74.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $45.3M $44.7M $52.4M $60.6M $74.8M
 
Total Liabilities and Equity $126.3M $165.5M $190.8M $231.9M $335.1M
Cash and Short Terms $15M $29.3M $29.3M $20.2M $36.3M
Total Debt -- -- -- $1.8M $1.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $40.3M $29.9M $24.1M $49.8M $22.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $74.9M $98.4M $125M $126.3M $247.9M
Inventory $3.1M $3.7M $2.1M $2.5M $4.4M
Prepaid Expenses $3.4M $4M $1.4M -- --
Other Current Assets $3.5M $4.2M $3.9M $5.4M $6.6M
Total Current Assets $125.2M $140.2M $156.5M $184M $281.1M
 
Property Plant And Equipment $2.7M $3.6M $4M $8.2M $13.1M
Long-Term Investments -- -- -- -- --
Goodwill $4M $17.1M $17.8M $19M $29.6M
Other Intangibles $3.8M $10.1M $18.7M $18.3M $46M
Other Long-Term Assets $176K $494K $393K $1.2M $863K
Total Assets $136.2M $171.7M $199.6M $232.4M $371.9M
 
Accounts Payable $85.3M $110.7M $127.9M $146.9M $240.6M
Accrued Expenses $6.2M $7.6M $8.7M $8M $21.6M
Current Portion Of Long-Term Debt -- -- $515K $535K $555K
Current Portion Of Capital Lease Obligations $428K $441K $482K $442K $533K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $91.9M $118.7M $137.6M $155.9M $275M
 
Long-Term Debt -- -- $1.4M $889K $334K
Capital Leases -- -- -- -- --
Total Liabilities $94M $122.3M $146.2M $164.7M $284.3M
 
Common Stock $53K $53K $53K $53K $53K
Other Common Equity Adj -$1.3M -$356K -$5.7M -$2.7M $1.2M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $42.2M $49.5M $53.4M $67.6M $87.7M
 
Total Liabilities and Equity $136.2M $171.7M $199.6M $232.4M $371.9M
Cash and Short Terms $40.3M $29.9M $24.1M $49.8M $22.1M
Total Debt -- -- $1.9M $1.4M $889K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $6.8M $4.5M $9.2M $12.5M $12.3M
Depreciation & Amoritzation $858K $1.1M $2M $2.5M $3.2M
Stock-Based Compensation $759K $1.3M $1.5M $1.9M $4.1M
Change in Accounts Receivable -$17.1M $26.7M -$28.6M -$35.8M -$29.6M
Change in Inventories -$1.3M -$2M $2.9M -$2.8M $3.6M
Cash From Operations $3.2M $38M $4.7M $4.6M $42.1M
 
Capital Expenditures $106K $23K $258K $2.5M $5M
Cash Acquisitions -- -$16.8M -- -$8.5M -$12.7M
Cash From Investing -$106K -$16.8M -$258K -$11M -$17.7M
 
Dividends Paid (Ex Special Dividend) -$3.1M -$3M -$3M -$3M -$3M
Special Dividend Paid
Long-Term Debt Issued -- $6.8M -- $2.1M $10M
Long-Term Debt Repaid -- -$6.8M -- -$336K -$13.6M
Repurchase of Common Stock -$86K -$3.7M -$544K -$655K -$1.7M
Other Financing Activities -- -$61K -$862K -- -$637K
Cash From Financing -$3.2M -$6.7M -$4.4M -$1.8M -$9M
 
Beginning Cash (CF) $14.9M $15M $29.3M $29.3M $20.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$9K $14.4M $55K -$8.3M $15.5M
Ending Cash (CF) $15M $29.3M $29.3M $20.2M $36.3M
 
Levered Free Cash Flow $3.1M $37.9M $4.5M $2.1M $37.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $530K $2.4M $2.2M $2.4M $5.5M
Depreciation & Amoritzation $247K $500K $695K $718K $1.4M
Stock-Based Compensation $637K $637K $777K $687K $904K
Change in Accounts Receivable $129K $2.9M -$11.4M $2.7M -$63.9M
Change in Inventories -$1M $421K -$418K $706K -$2.8M
Cash From Operations -$3.9M $8.4M $6.5M $8.7M -$3.6M
 
Capital Expenditures $1K $21K $827K $1.2M $1.2M
Cash Acquisitions -- -- -$8.5M -- -$20.7M
Cash From Investing -$1K -$21K -$9.3M -$1.2M -$21.9M
 
Dividends Paid (Ex Special Dividend) -$742K -$747K -$748K -$753K -$761K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$127K -$130K -$169K
Repurchase of Common Stock -$81K -$207K -$126K -$248K -$315K
Other Financing Activities -$61K -$863K -- -$54K -$2K
Cash From Financing -$884K -$1.8M -$1M -$1.2M -$1.2M
 
Beginning Cash (CF) $45M $23.8M $29.3M $43.9M $48.4M
Foreign Exchange Rate Adjustment $14K -$383K -$1.5M -$486K $502K
Additions / Reductions -$4.7M $6.5M -$3.8M $6.4M -$26.7M
Ending Cash (CF) $40.3M $29.9M $24.1M $49.8M $22.1M
 
Levered Free Cash Flow -$3.9M $8.4M $5.7M $7.6M -$4.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4M $8.3M $11.2M $11.8M $16.9M
Depreciation & Amoritzation $879K $2M $2.2M $3M $4.2M
Stock-Based Compensation $1.2M $1.5M $1.8M $3.8M $3.5M
Change in Accounts Receivable $22.9M -$14.4M -$29.6M $116K -$84.2M
Change in Inventories -$638K -$511K $1.6M -$402K $664K
Cash From Operations $38.1M $12.9M $5M $35.1M $21.5M
 
Capital Expenditures $34K $193K $1.5M $5.2M $4.4M
Cash Acquisitions -$1.1M -$15.6M -$8.5M -$1K -$33.4M
Cash From Investing -$1.2M -$18.8M -$7.1M -$5.2M -$37.8M
 
Dividends Paid (Ex Special Dividend) -$3M -$3M -$3M -$3M -$3M
Special Dividend Paid
Long-Term Debt Issued $6.8M -- $2.1M $10M --
Long-Term Debt Repaid -$6.8M -- -$210K -$10.5M -$7.9M
Repurchase of Common Stock -$3.6M -$473K -$670K -$1.6M -$1.3M
Other Financing Activities -- -- -- -- --
Cash From Financing -$6.7M -$4.3M -$1.7M -$5.7M -$12.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $30.3M -$10.2M -$3.7M $24.2M -$28.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $38.1M $12.7M $3.5M $29.9M $17.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.9M $5.8M $7.7M $7.1M $11.6M
Depreciation & Amoritzation $683K $1.5M $1.7M $2.2M $3.2M
Stock-Based Compensation $1M $1.3M $1.5M $3.4M $2.8M
Change in Accounts Receivable $36.6M -$4.5M -$5.5M $30.4M -$24.1M
Change in Inventories -$235K $1.3M -$102K $2.2M -$690K
Cash From Operations $32.5M $7.5M $7.8M $38.4M $17.8M
 
Capital Expenditures $20K $190K $1.5M $4.2M $3.6M
Cash Acquisitions -$1.1M -- -$8.5M -- -$20.7M
Cash From Investing -$1.2M -$3.2M -$10M -$4.2M -$24.3M
 
Dividends Paid (Ex Special Dividend) -$2.3M -$2.2M -$2.2M -$2.3M -$2.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $6.8M -- $2.1M $10M --
Long-Term Debt Repaid -$6.8M -- -$210K -$10.4M -$4.7M
Repurchase of Common Stock -$3.6M -$394K -$520K -$1.4M -$1M
Other Financing Activities -$61K -$863K -- -$638K -$152K
Cash From Financing -$5.9M -$3.5M -$822K -$4.7M -$8.1M
 
Beginning Cash (CF) $71.6M $86.9M $95.6M $125.9M $128.2M
Foreign Exchange Rate Adjustment -$138K -$195K -$2.2M $81K $458K
Additions / Reductions $25.5M $781K -$3M $29.5M -$14.6M
Ending Cash (CF) $96.9M $87.5M $90.4M $155.4M $114.1M
 
Levered Free Cash Flow $32.5M $7.3M $6.3M $34.2M $14.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock